News | University of Oxford
HomeNews

News
Oxford COVID-19 Vaccine

Development of Oxford COVID-19 vaccine expands into US Phase III clinical trial

Research
Coronavirus
COVID-19 vaccine
Medical Science Division
Researcher at Oxford's Jenner Institute works in a laboratory.

New study reveals Oxford coronavirus vaccine produces strong immune response

COVID-19 vaccine
Research
Coronavirus
Image of Cornavirus

Trial of Oxford COVID-19 vaccine starts in Brazil

COVID-19 vaccine
Health
Coronavirus
The Duke of Cambridge has today visited the University of Oxford’s Oxford Vaccine Group

The Duke of Cambridge visits Oxford Vaccine Centre

Research
Coronavirus
COVID-19 vaccine
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

COVID-19 vaccine
Coronavirus
Research
Partnerships
Next steps towards broad and equitable global access

Oxford University’s COVID-19 vaccine: next steps towards broad and equitable global access

COVID-19 vaccine
Coronavirus
Research
Partnerships
Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine

Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine

Coronavirus
COVID-19 vaccine
Health
Research
Landmark partnership announced for development of COVID-19 vaccine

Oxford COVID-19 vaccine to begin phase II/III human trials

Coronavirus
Research
Health
COVID-19 vaccine
Nye Founders Chris Tan, Dr Alexander Finlayson, and Dr Imran Mahmud

Health-tech start-up Nye supports Oxford’s COVID-19 vaccine trial

Foundry
Coronavirus
COVID-19 vaccine
Innovation
Pipette ove test tubes

Funding and manufacturing boost for UK vaccine programme

Research
Coronavirus
Funding
COVID-19 vaccine

Pages